Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Teal Valley T.TV


Primary Symbol: P.TEAL

Teal is a Canadian, pharmaceutical & NHP manufacturer selling to Canada’s national, chain drug stores, presently expanding its portfolio to include cannabinoid-based products utilizing proprietary formulations & extractions for both the global Rx & recreational markets.


P.TEAL - Post by User

Post by tenacious1on Mar 25, 2022 10:24pm
318 Views
Post# 34547563

Objective look at Q1 possible results

Objective look at Q1 possible results1. The company has indicated that Q1 and Q4 will be weaker than Q2 and Q3 because of scheduling issues. That suggests AISC will be higher in Q1 spreading cash costs over reduced production.
2. Average zinc prices are over $1.70 for the quarter. 
A quarter of sales will be at 1.25 from Caribou, the rest at 1.70. Remember, these are accounting numbers only, which try to reflect reality, but can’t take into account actual sales/production/settlement payments etc with the forward accounting assumptions which try to reflect future settlement payments which are 3-4 months later.

3. No matter how you slice and dice it, it seems clear that, given market conditions of supply and demand, energy issues in Europe, and market disruptions generally in base metals, TV is going to be generating  very amazing cash flows and p/e’s in 2022.
4. Turning to other market influences, the RP2 financing, which overhangs the market, should be arranged on favourably terms now that cash flow is so impressive.
5. The ROL at Caribou will be updated in H1. It will either be terminated as not viable, or will have a PEA that suggests something positive with further  capex down the road.
I welcome any and all reasoned comment. 
<< Previous
Bullboard Posts
Next >>